Malaria
The EU's Nasty Bite
Jueves, Enero 8, 2009
This study discusses the potential consequences of new EU regulations that prohibit production of certain chemicals used in the manufacture of pesticides.
What do AIDS activists want more money for?
IPN Opinion article
UNAIDS has inflated its HIV/AIDS figures for years and now claims the natural decline of AIDS as a victory (it started before UNAIDS was set up): Bill Clinton at the international AIDS conference in Vienna attacked the waste of money but this analyst says UNAIDS should just be shut down. In fact, AIDS is not even the top killer in Africa, let alone anywhere else.
Mosquito nets can't cure malaria
IPN Opinion article
I wish Cheryl Cole a speedy recovery, and hope she'll consider using her fame to support truly effective ways of tackling malaria.
Producing Medicines for Chronic Diseases in Less Developed Countries
Jueves, Junio 10, 2010
The HIV / AIDS crisis bears a number of clinical and practical similarities to the new challenge of producing drugs to treating chronic disease in lower-income countries, providing a useful case study when determining effective strategies. A new literature review by Philip Stevens, the second in a three-part series, examines what can be learned from the global response to HIV / AIDS – and reveals some costly mistakes that should not be repeated.
The new boom in malaria
World Malaria Day, 25 April - The biggest threat is the rise of drug-resistant parasites due to fake and sub-standard medicines. As with other drugs before, this resistance is emerging all along the Mekong, from Cambodia to Myanmar, where the wonder-drug artemisinin is already failing: this threatens malaria victims everywhere.
Killing the malaria killer
IPN Opinion article
On World Malaria Day, activists and governments discuss many weapons against the disease except one of the most effective: DDT
The new boom in malaria
IPN Opinion article
The outlook for malaria remains poor because of fake drugs and bad governance
Combating fake medicines: health, IP and global politics
Issues such as intellectual property rights have prevented action in tackling the global menace of counterfeit and substandard medicines
